News Releases

Biostem U.S., Corporation (OTCQB: BOSM) (PINKSHEETS: BOSM) Chief Executive Officer, Dwight Brunoehler announced today that the Board of Directors has authorized a three for one forward split of the company's common stock. The split has already received approval from FINRA and will be effective as of the start of trading on April 30, 2012.

About Biostem U.S., Corporation

Biostem U.S., Corporation is a fully reporting Nevada corporation with offices in Clearwater, Florida. Biostem is a technology licensing company with proprietary technology centered around providing hair re-growth using human stem cells. The company also intends to train and license selected physicians to provide Regenerative Cellular Therapy treatments to assist the body's natural approach to healing tendons, ligaments, joints and muscle injuries by using the patient's own stem cells. Biostem U.S. is seeking to expand its operations worldwide through licensing of its proprietary technology and acquisition of existing stem cell related facilities. The company's goal is to operate in the international biotech market, focusing on the rapidly growing regenerative medicine field, using ethically sourced adult stem cells to improve the quality and longevity of life for all mankind.

More information on Biostem U.S., Corporation can be obtained through www.biostemus.com, or by calling Fox Communications Group 310-974-6821.

Contact:
Fox Communications Group
310-974-6821